Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE